You need an account to export. Log in to download this list.

You need an account to export. Log in to download this list.

Publications

338 rows, counting the CV or the Scholar profile
Export

Core

Profile fields

Catalogue

Year Title Cites
2026 A Combinatorial Synthetic Strategy for Developing Genome-Editing Protein-Delivery Agents Targeting Mouse Retina David R. Liu · Nature Communications — 2026 AI-guided Re-design of Laboratory-Evolved Reverse Transcriptases Enhances Prime Editing in Human Cells and in Animals David R. Liu · Nature Biotechnology 3 2026 AI-redesigned Starting Points and Outcomes Enhance Protein Evolution David R. Liu · Nature — 2026 Directed Evolution of Small RNA-Stabilizing Motifs that Improve Prime Editing David R. Liu · Nature Biotechnology — 2026 Efficient Prime Editing In Vivo and In Vitro Using Lipid Nanoparticles David R. Liu · Nature Nanotechnology — 2026 Evolution of Botulinum Neurotoxin Serotype X Proteases to Induce Inflammatory Cell Death in Cancer Cells David R. Liu · Nature Biotechnology — 2026 In Vivo Adenine Base Editing Ameliorates Dravet Syndrome Phenotypes in a Mouse Model David R. Liu · Science Translational Medicine — 2026 In Vivo Base Editing Rescues Liver Pathophysiology and Peroxisome Dysfunction in a Mouse Model of Zellweger Spectrum Disorder David R. Liu · Nature Biomedical Engineering — 2026 Mechanistic Machine Learning for Prediction of Prime Editing Outcomes David R. Liu · Nature Biotechnology — 2026 Restoration of the immune system with base editing and non-genotoxic conditioning in a Rag2 point-mutant mouse model David R. Liu · Molecular Therapy — 2026 Small-Molecule Binding and Sensing with a Designed Protein Family David R. Liu · Nature Communications — 2026 Synonymous Editing Alters Ion Channel Function, Favoring Prime Editing for Retinal Disease Correction David R. Liu · International Journal of Biological Sciences — 2026 Virus-like Particles Enable Targeted Gene Engineering and Pooled CRISPR Screening in Primary Human Myeloid Cells David R. Liu · Nature Biotechnology — 2025 Adenine Base Editing Rescues Pathogenic Phenotypes in Tissue Engineered Vascular Model of Hutchinson-Gilford Progeria Syndrome David R. Liu · APL Bioengineering — 2025 A Molecular Glue Approach to Control the Half-Life of CRISPR-Based Technologies David R. Liu · Journal of the American Chemical Society — 2025 Branched, Chemically Modified Poly(A) Tails Enhance the Translation Capacity of mRNA David R. Liu · Nature Biotechnology — 2025 Correcting a Pathogenic Mitochondrial DNA Mutation by Base Editing in Mice David R. Liu · Science Translational Medicine — 2025 Directed Evolution of Engineered Virus-Like Particles with Improved Production and Transduction Efficiencies David R. Liu · Nature Biotechnology — 2025 Efficient Site-Specific Integration of Large Genes in Mammalian Cells Via Continuously Evolved Recombinases and Prime Editing David R. Liu · Nature Biomedical Engineering — 2025 Engraftment and Persistence of HBB Base-Edited Hematopoietic Stem Cells in Nonhuman Primates David R. Liu · Science Translational Medicine — 2025 EvoAI Enables Extreme Compression and Reconstruction of the Protein Sequence Space David R. Liu · Nature Methods — 2025 GFP-on Mouse Model for Interrogation of In Vivo Gene Editing David R. Liu · Nature Communications — 2025 High Throughput Evaluation of Genetic Variants with Prime Editing Sensor Libraries David R. Liu · Nature Biotechnology — 2025 In Vivo Base Editing Extends Lifespan of a Humanized Mouse Model of Prion Disease David R. Liu · Nature Medicine — 2025 In Vivo Base Editing of Angptl3 via Lipid Nanoparticles to Treat Cardiovascular Disease David R. Liu · Molecular Therapy Nucleic Acids — 2025 In Vivo Prime Editing Rescues Alternating Hemiplegia of Childhood in Mice David R. Liu · Cell — 2025 In Vivo Prime Editing Rescues Photoreceptor Degeneration in Nonsense Mutant Retinitis Pigmentosa David R. Liu · Nature Communications — 2025 Modulating Collagen I Expression in Fibroblasts by CRISPR-Cas9 Base Editing of the Collagen 1A1 Promoter David R. Liu · International Journal of Molecular Sciences — 2025 Multiplex Base Editing to Protect from CD33 Directed Drugs for Immune and Gene Therapy David R. Liu · Nature Communications — 2025 Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease David R. Liu · New England Journal of Medicine 441 2025 Precisely Defining Disease Variant Effects in CRISPR-Edited Single Cells David R. Liu · Nature — 2025 Prime Editing-Installed Suppressor tRNAs for Disease-Agnostic Genome Editing David R. Liu · Nature — 2025 Programmable Gene Insertion in Human Cells with a Laboratory-Evolved CRISPR-Associated Transposase David R. Liu · Science — 2025 Safer and Efficient Base Editing and Prime Editing Via Ribonucleoproteins Delivered Through Optimized Lipid-Nanoparticle Formulations David R. Liu · Nature Biomedical Engineering — 2025 Scalable Purification Enables High-Quality Virus-Like Particles for Therapeutic Translation David R. Liu · Journal of Biological Chemistry — 2025 Systematic Empirical Evaluation of Individual Base Editing Targets: Validating Therapeutic Targets in USH2A and Comparison of Methods David R. Liu · Molecular Therapy — 2025 Systematic Optimization of Prime Editing for the Efficient Functional Correction of CFTR F508del in Human Airway Epithelial Cells David R. Liu · Nature Biomedical Engineering — 2025 TIGER: A Novel tdTomato In-Vivo Genome-Editing Reporter Mouse for Investigating Precision-Editor Delivery Approaches David R. Liu · Proceedings of the National Academy of Sciences — 2025 Ultrasmall Chemogenetic Tags with Group-Transfer Ligands David R. Liu · Angewandte Chemie International Edition — 2024 Adenine Transversion Editors Enable Precise, Efficient A•T-To-C•G Base Editing in Mammalian Cells and Embryos David R. Liu · Nature Biotechnology — 2024 Amphiphilic Shuttle Peptide Delivers Base Editor Ribonucleoprotein to Correct the CFTR R553X Mutation in Well-Differentiated Airway Epithelial Cells David R. Liu · Nucleic Acids Research — 2024 A Prime Editor Mouse to Model a Broad Spectrum of Somatic Mutations In Vivo David R. Liu · Nature Biotechnology — 2024 Bone Marrow Homing Lipid Nanoparticles for Genome Editing in Diseased and Malignant Hematopoietic Stem Cells David R. Liu · Nature Nanotechnology — 2024 Continuous Evolution of Compact Protein Degradation Tags Regulated by Selective Cereblon Molecular Glues David R. Liu · Science — 2024 Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours David R. Liu · Nature Reviews Cancer · Scholar only 341 2024 Efficient Prime Editing in Mouse Brain, Liver and Heart with Dual AAVs David R. Liu · Nature Biotechnology — 2024 Efficient Prime Editing in Two-Cell Mouse Embryos Using PEmbryo David R. Liu · Nature Biotechnology — 2024 Engineered Virus-Like Particles for Transient Delivery of Prime Editor Ribonucleoprotein Complexes In Vivo David R. Liu · Nature Biotechnology — 2024 Introducing a Hemoglobin G-Makassar Variant in HSCs by In Vivo Base Editing Treats Sickle Cell Disease in Mice David R. Liu · Molecular Therapy — 2024 In Vivo Photoreceptor Base Editing Ameliorates Rhodopsin-E150K Autosomal-Recessive Retinitis Pigmentosa in Mice David R. Liu · Proceedings of the National Academy of Sciences —
Back to the list

2026 · article · journal

A Combinatorial Synthetic Strategy for Developing Genome-Editing Protein-Delivery Agents Targeting Mouse Retina

Nature Communications · David R. Liu

in CV
noneScholar citations
noneOpenAlex citations

From the CV

lines 1608–1611 · published

300. "A Combinatorial Synthetic Strategy for Developing Genome-Editing Protein-Delivery Agents TargetingMouse Retina" Palczewski, K; Tochtrop, G.; Zhang, J.; Šmidák, R.; Du, S.; Holubowicz, S.; Felgner, P.;Felgner, J.; Palczewska, G.; Menezes, C.; Risaliti, E.; Holubowicz,, M.; Hu, Y.; Shayegan, M.; Li, B.; Chen,P.; Liu, D.R.; Xing, L.; Dong, Z.; Ma, X. Nature Communications, in press, available online (2026).

Peer reviewed
yes
First author
Palczewski
Co-authors
Palczewski, K; Tochtrop, G.; Zhang, J.; Šmidák, R.; Du, S.; Holubowicz, S.; Felgner, P.; Felgner, J.; Palczewska, G.; Menezes, C.; Risaliti, E.; Holubowicz,, M.; Hu, Y.; Shayegan, M.; Li, B.; Chen, P.; Liu, D.R.; Xing, L.; Dong, Z.; Ma, X.
Subfield
other
Method
none
Invited
none
Publisher
none
Reprint or translation
none
DOI
10.1038/s41467-026-69077-w

Where each field came from

FieldCVOpenAlexScholar
title A Combinatorial Synthetic Strategy for Developing Genome-Editing Protein-Delivery Agents Targeting Mouse Retina (used)
year 2026 (used)
venue Nature Communications (used)
kind article (used)
DOI 10.1038/s41467-026-69077-w (used)
first author Palczewski (used)

The value in bold is the one the record uses.

How the records were joined

No decision recorded; a single record.